文献速递头颈外科

肌肉减少症可预测接受根治性治疗的头颈癌患者短期治疗相关毒性:系统综述与Meta分析

Sarcopenia predicts short-term treatment-related toxicity in patients undergoing curative-intent therapy for head and neck cancer: A systematic review and meta-analysis.
PubMed 文献 · Head Neck · 2024-02-14

该系统综述与Meta分析纳入16项观察性研究、共3187例头颈癌患者,评估肌肉减少症对严重治疗毒性和治疗耐受性的影响。合并OR显示肌肉减少症与严重治疗毒性显著相关(OR 2.22,95%CI 1.50-3.29),与治疗耐受性无显著相关(OR 0.84-2.32区间跨1)。接受根治性头颈癌治疗的患者中,肌肉减少症者发生短期治疗相关毒性的风险是两倍以上。

要点

  • 肌肉减少症与头颈癌根治性治疗中严重治疗毒性显著相关(OR 2.22,95%CI 1.50-3.29)。
  • 肌肉减少症与治疗耐受性无显著相关(OR 1.40,95%CI 0.84-2.32,未达统计学显著)。
  • 肌肉减少症对严重毒性的影响在 upfront手术(OR 2.03,95%CI 1.22-3.37)与根治性放疗(OR 2.24,95%CI 1.18-4.27)中相似。

核心结论

  • 接受根治性头颈癌治疗的肌肉减少症患者发生短期治疗相关毒性的风险是非肌肉减少症患者的两倍以上。

研究设计与样本

  • 系统综述与Meta分析,检索多个数据库,纳入16项观察性研究、共3187例头颈癌患者,采用逆方差随机效应模型进行合并分析。

主要发现

  • 肌肉减少症与严重治疗毒性的合并OR为2.22(95%CI 1.50-3.29)。
  • 肌肉减少症与治疗耐受性的合并OR为1.40(95%CI 0.84-2.32),未达统计学显著。
  • 肌肉减少症对短期严重治疗毒性的影响在 upfront手术(OR 2.03,95%CI 1.22-3.37)与根治性放疗(OR 2.24,95%CI 1.18-4.27)中相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sarcopenia is an increasingly recognized biomarker associated with poorer outcomes. The objective of this study was to ascertain the effect of sarcopenia on treatment tolerance and short-term toxicity in head and neck cancer (HNC). A systematic review was performed using multiple databases. An inverse-variation, random-effects model was used to perform the meta-analysis to evaluate the effect of sarcopenia on severe treatment toxicity and poor treatment tolerance. Sixteen observational studies, including 3187 patients with HNC, were analyzed. The combined odds ratio (OR) for severe treatment toxicity and tolerance was 2.22 (95%CI 1.50-3.29) and 1.40 (95%CI 0.84-2.32), respectively. The effect of sarcopenia on short-term severe treatment toxicity was similar with upfront surgery (OR 2.03, 95%CI 1.22-3.37) and definitive radiotherapy (OR 2.24, 95%CI 1.18-4.27) Patients with sarcopenia are more than twice as likely to suffer a short-term treatment-related toxicity when undergoing curative-intent HNC treatment.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Mascarella MA, Ferdus J, Vendra V, et al. Sarcopenia predicts short-term treatment-related toxicity in patients undergoing curative-intent therapy for head and neck cancer: A systematic review and meta-analysis. Head Neck. 2024. PMID: 38353170. doi:10.1002/hed.27688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。